Company / Working Capital
Kodiak Sciences Inc. Working Capital History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$146.4M
FY2024
5-year range
$146.4M / $940.6M
FY2020-FY2024
Trend
-40.9%
vs FY2023
Sector context
#183 of 215
Health Care
What the data says
Kodiak Sciences Inc.'s working capital of $146M is lower than 85% of companies in the Health Care sector (FY2024). Working Capital has declined for 4 consecutive years, from $941M in FY2020 to $146M in FY2024.
Based on SEC 10-K filings.
$146M in FY2024 with a 5-year CAGR of -14.9%.
Declined from $434M to $146M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -39.8%
- 5-Year CAGR
- -14.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 215This company $146.4M Sector average $957.8M
▼
-84.7% below sector average
Key checks
Key Insights
- Kodiak Sciences Inc.'s working capital has declined for 4 consecutive years.
- 5-year CAGR of -14.9%, indicating a declining trend.
- In FY2024, working capital decreased 40.9% year-over-year.
- Ranks #183 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $146.4M | -40.9% |
| FY2023 | $247.6M | -42.9% |
| FY2022 | $433.5M | -35.3% |
| FY2021 | $670.1M | -28.8% |
| FY2020 | $940.6M | +187.2% |
| FY2019 | $327.5M | +282.5% |
| FY2018 | $85.6M | +1232.1% |
| FY2017 | -$7.6M | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026